Dr. Galsky on Progression on Immunotherapy in Bladder Cancer – OncLive
|
Dr. Galsky on Progression on Immunotherapy in Bladder Cancer
OncLive Matthew Galsky, MD, professor of medicine, hematology, and medical oncology, Mount Sinai Hospital, discusses the next steps following progression on immunotherapy for patients with bladder cancer. There is a growing understanding of the resistance to … |
